Exact Mass: 308.1861736

Borrecapine

Tetraphyllicine

(1R,9R,10S,12R,13E,16S,18R)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-ol

6960-01-6

3beta-Chloro-5-androsten-17beta-ol

C19H29ClO (308.1906814)

2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone

2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methylnaphthalene-1,4-dione

(R)-1-O-b-D-glucopyranosyl-1,3-octanediol

2-(hydroxymethyl)-6-[(3-hydroxyoctyl)oxy]oxane-3,4,5-triol

(R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is a constituent of apples Constituent of apples. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes.

Gestrinone

(10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1,6,16-trien-5-one

Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720) [HMDB] Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

Indecainide

9-{3-[(propan-2-yl)amino]propyl}-9H-fluorene-9-carboximidate

Indecainide is only found in individuals that have used or taken this drug. It is a rarely used antidysrhythmic. Indecainide has local anesthetic activity and belongs to the membrane stabilizing (Class 1) group of antiarrhythmic agents; it has electrophysiologic effects characteristic of the IC class of antiarrhythmics.Indecainide acts on sodium channels on the neuronal cell membrane, limiting the spread of seizure activity and reducing seizure propagation. The antiarrhythmic actions are mediated through effects on sodium channels in Purkinje fibers. C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

(+/-)-nitraraine|(-)-nitraraine|Alloyohimb-16-en-16-methanol|Nitraraine|yohimb-16-en-16-yl-methanol

(+)-aristotelinone|Aristotelinone

3,5-dimethoxy-4-prenylstilbene

Aristolasicone

sarcidumitol

C14H28O7

N(1)-methyl-14,15-didehydro-12-hydroxyaspidofractinine

normacusine B

Ariston

MS000140343

17-methoxy-sarpagane|O-Methyl-normacusin B

8-oxo-9-dehydrohobartine

ervataine

(+)-(4aS,12bS)-4,4,12b-trimethyl-1,2,3,4,4a,5,6,12b-octahydrobenzo[a]anthracene-8,11-dione|(+)-cyclozonarone|Cyclozonarone

Aristoserratin|Aristoserratine

NSC286326

Rosibiline

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

NCGC00380218-01!(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845933]

NCGC00380218-01!(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845933]

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based: Match]

NCGC00380218-01!(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based: Match]

2-Pyrrolidinone, 4-(2-aminoethyl)-1-ethyl-3,3-diphenyl- (AHR 5904)

Gestrinone

13-ethyl-17α-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one

G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

3β-CHLOROANDROSTANONE

C19H29ClO (308.1906814)

Indecainide

9-(3-(Isopropylamino)propyl)-9-fluorenylcarboxamid;9-(3-(Isopropylamino)propyl))fluorene-9-carboxamide;Indecainida [Spanish];Indecainidum [Latin];Ricainid;Ricainide

C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

(R)-1-O-b-D-glucopyranosyl-1,3-octanediol

2-(hydroxymethyl)-6-[(3-hydroxyoctyl)oxy]oxane-3,4,5-triol

Ubisindine

DESOXY-TETRAENE(5-ST)

C16H25BO5 (308.17949500000003)

2-Methoxycarbonyl-1-phenylethylboronic acid pinacol ester

1-BOC-2-[(4-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-3-(2-FLUORO-BENZYLAMINO)-PIPERIDINE

1-BOC-3-(3-FLUORO-BENZYLAMINO)-PIPERIDINE

1-BOC-3-(4-FLUORO-BENZYLAMINO)-PIPERIDINE

1-BOC-3-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-3-[(3-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE

1-BOC-3-[(3-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-3-[(4-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE

1-BOC-3-[(4-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-4-(2-FLUORO-BENZYLAMINO)-PIPERIDINE

2′-(Di-tert-butylphosphino)acetophenone ethylene ketal

C18H29O2P (308.1905064)

tert-butyl 4-(aminomethyl)-4-(4-fluorophenyl)piperidine-1-carboxylate

11-MERCAPTOUNDECYLTRIMETHOXYSILANE

C14H32O3SSi (308.1841322)

1-BOC-4-(4-FLUORO-BENZYLAMINO)-PIPERIDINE

Bisphenol A diallyl ether

Diallyl bisphenol A

N-(1-benzyl-4-phenylpiperidin-4-yl)acetamide

1-BENZYL-4,5-DIHYDRO-3H-SPIRO[BENZO[B][1,4]OXAZEPINE-2,4-PIPERIDINE]

methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate

C12H28N2O5Si (308.1767398)

4-(Diphenylmethyl)-1-(2,3-epoxypropyl)piperazine

1-BOC-3-[(2-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE

HIV-1 integrase inhibitor 8

1-BOC-2-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE

1-BOC-2-[(3-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE

tert-Butyl 4-(benzylamino)-3-fluoropiperidine-1-carboxylate

EDTA-d16

C10D16N2O8 (308.191096448)

N-(2-adamantylcarbamothioyl)hexanamide

C17H28N2OS (308.1922238)

3beta-Chloro-5-androsten-17beta-ol

C19H29ClO (308.1906814)

a Jasmonate-valine

C17H26NO4- (308.1861736)

(-)-jasmonate-L-valine

C17H26NO4- (308.1861736)

[3-Carboxy-2-(4-phenylbutanoyloxy)propyl]-trimethylazanium

C17H26NO4+ (308.1861736)

2,6-Diphenyl-3-propyl-4-piperidinone oxime

(8S,13S,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

C17H28O3Si (308.18076179999997)

2-[4-(2-Trimethylsilyloxy-2-methylpropyl)phenyl]propanoic acid methyl ester

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol

(1R,9R,10S,12R,13E,16S,18R)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-ol

CID 6325075

Menaquinone

ST 21:6;O2

(1s,14r,19r)-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-2(10),4,6,8,17-pentaen-17-ylmethanol

(1r,12s,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraen-11-one

(4as,12bs)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

(2s,3r,12br)-3-ethenyl-2-[(1e)-2-methoxyethenyl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

3-ethenyl-2-(2-methoxyethenyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

(6e)-1,7-diphenylhept-6-en-3-yl acetate

4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione

(2r,3r,4s,5s,6r)-2-{[(3r)-3-ethyl-4-hydroxy-4-methylpentyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-ol

affinisine

{"Ingredient_id": "HBIN014774","Ingredient_name": "affinisine","Alias": "NA","Ingredient_formula": "C20H24N2O","Ingredient_Smile": "CC=C1CN2C3CC1C(C2CC4=C3N(C5=CC=CC=C45)C)CO","Ingredient_weight": "308.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "669","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101286222","DrugBank_id": "NA"}

(1r,9r,10s,12r,13e,16s,17s,18s)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-ol

[(1s,14r,15z)-15-ethylidene-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-13-yl]methanol

[(1s,12s,13r,15e)-15-ethylidene-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-13-yl]methanol

(1s,2r,4r,12s,15s,18r)-14,14,18-trimethyl-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-16-one

1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraen-11-one

(1r,10s,13e,16s)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-trien-18-ol

[(1s,12s,13s,14r,15e)-15-ethylidene-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-13-yl]methanol